Giant cell tumor of the bone: an evaluation of prognostic factors associated with local recurrence and a comparison with the current literature

Aim: Results of the surgical and medical treatments giant cell tumor bone (GCT) in terms local recurrence prognostic factors associated with are evaluated this study. Material Method: Patients treated either or methods for GCT between 2011 2021 were retrospectively evaluated. Gender age patients, localization tumors, existence pathological fractures, grade tumor, soft tissue expansion, resection types Postoperative metastasis analyzed, risk determined. Results: The mean 117 patients (51 female 66 male) was 36.1±9.3 years. follow-up 71.2±48.3 months. Forty Grade I, 56 II, 21 3, according to Campanacci Grading System. Soft expansion present (17.9%) patients. 59.8% undergone intralesional curettage, 32.4% marginal wide excision combined adjuvant therapy liquid nitrogen poly-methyl methacrylate (PMMA) application, 5.9% have en bloc reconstruction arthrodesis. Two suffering from sacral involvement radiotherapy. There after surgery 19 (16.2%) Conclusion: Local is an important cause morbidity treatment GCT, which a benign but aggressive bone. In study, we investigated causes recurrence, found be development recurrence.